Found: 28
Select item for more details and to access through your institution.
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 2, p. 302, doi. 10.1002/ana.27009
- By:
- Publication type:
- Article
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 8, p. 1, doi. 10.1111/ene.16331
- By:
- Publication type:
- Article
Rituximab treatment in pediatric‐onset multiple sclerosis.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 5, p. 1, doi. 10.1111/ene.16228
- By:
- Publication type:
- Article
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 1, p. 177, doi. 10.1093/brain/awad374
- By:
- Publication type:
- Article
Comparison Between the Video Head Impulse Test and Caloric Irrigation During Acute Vertigo.
- Published in:
- Indian Journal of Otolaryngology & Head & Neck Surgery, 2022, v. 74, p. 4475, doi. 10.1007/s12070-022-03123-z
- By:
- Publication type:
- Article
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 9, p. 1449, doi. 10.1002/acn3.51646
- By:
- Publication type:
- Article
Free vitamin D<sub>3</sub> index and vitamin D‐binding protein in multiple sclerosis: A presymptomatic case–control study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 8, p. 2335, doi. 10.1111/ene.15407
- By:
- Publication type:
- Article
Internet-based vestibular rehabilitation versus standard care after acute onset vertigo: a study protocol for a randomized controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 12, p. 1814, doi. 10.1177/1352458520932798
- By:
- Publication type:
- Article
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 9, p. 3072, doi. 10.1111/ene.14961
- By:
- Publication type:
- Article
Normative video head impulse test data in subjects with and without vascular risk factors.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2021, v. 278, n. 7, p. 2619, doi. 10.1007/s00405-020-06332-w
- By:
- Publication type:
- Article
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 6, p. 2161, doi. 10.1007/s00415-021-10399-8
- By:
- Publication type:
- Article
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 2, p. 184, doi. 10.1001/jamaneurol.2019.3365
- By:
- Publication type:
- Article
Effectiveness of care in acute dizziness presentations.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2019, v. 276, n. 9, p. 2389, doi. 10.1007/s00405-019-05470-0
- By:
- Publication type:
- Article
Inflammatory activity and vitamin D levels in an MS population treated with rituximab.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 1, p. 1, doi. 10.1177/2055217319826598
- By:
- Publication type:
- Article
Dizziness and the Acute Vestibular Syndrome at the Emergency Department: A Population-Based Descriptive Study.
- Published in:
- European Neurology, 2018, v. 79, n. 1/2, p. 5, doi. 10.1159/000481982
- By:
- Publication type:
- Article
Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 3, p. 320, doi. 10.1001/jamaneurol.2017.4011
- By:
- Publication type:
- Article
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rituximab in paediatric onset multiple sclerosis: a case series.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 2, p. 322, doi. 10.1007/s00415-015-7979-x
- By:
- Publication type:
- Article
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level – YES.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1239, doi. 10.1177/1352458515578773
- By:
- Publication type:
- Article
The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 747, doi. 10.1177/1352458513507820
- By:
- Publication type:
- Article
Epstein–Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 13, p. 1692, doi. 10.1177/1352458513507625
- By:
- Publication type:
- Article
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 12, p. 1587, doi. 10.1177/1352458513483888
- By:
- Publication type:
- Article
Smoking as a risk factor for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1022, doi. 10.1177/1352458512470862
- By:
- Publication type:
- Article
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1046, doi. 10.1177/1352458512472752
- By:
- Publication type:
- Article
Timing of cigarette smoking as a risk factor for multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2013, v. 6, n. 3, p. 205, doi. 10.1177/1756285613479427
- By:
- Publication type:
- Article
Neurofilament light as a prognostic marker in multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 3, p. 287, doi. 10.1177/1352458509359725
- By:
- Publication type:
- Article